Money
Questions arise over Haemanthus and its laser-based diagnostic claims
A new startup, Haemanthus, is drawing scrutiny for its laser-based diagnostic technology and ambitious development timelines, echoing the patterns of the defunct biotech firm Theranos.
October 28, 2026, 09:00 PM·The Verge


